药品注册申请号:080365
申请类型:ANDA (仿制药申请)
申请人:DR REDDYS
申请人全名:DR REDDYS LABORATORIES LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML No No AP 1974/02/13 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
1974/02/13 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/02/05 SUPPL-167(补充) Approval Labeling-Package Insert STANDARD
2017/02/23 SUPPL-166(补充) Approval Labeling-Package Insert STANDARD
2015/11/03 SUPPL-165(补充) Approval Labeling-Package Insert
1999/02/19 SUPPL-163(补充) Approval Manufacturing (CMC)-Microbiology-Processing
1999/02/02 SUPPL-162(补充) Approval Manufacturing (CMC)-Microbiology-Processing
1998/03/27 SUPPL-160(补充) Approval Manufacturing (CMC)
1996/12/04 SUPPL-161(补充) Approval Manufacturing (CMC)-Microbiology-Processing
1995/08/16 SUPPL-159(补充) Approval Manufacturing (CMC)
1992/05/27 SUPPL-157(补充) Approval Manufacturing (CMC)
1992/05/11 SUPPL-158(补充) Approval Labeling
1991/07/02 SUPPL-152(补充) Approval Manufacturing (CMC)
1991/07/02 SUPPL-151(补充) Approval Manufacturing (CMC)
1991/07/02 SUPPL-150(补充) Approval Manufacturing (CMC)
1991/04/10 SUPPL-156(补充) Approval Labeling
1990/01/11 SUPPL-155(补充) Approval Labeling
1989/10/16 SUPPL-153(补充) Approval Manufacturing (CMC)
1989/10/16 SUPPL-149(补充) Approval Manufacturing (CMC)
1989/10/16 SUPPL-148(补充) Approval Manufacturing (CMC)
1989/04/20 SUPPL-138(补充) Approval Bioequivalence
1989/04/18 SUPPL-147(补充) Approval Manufacturing (CMC)
1989/04/18 SUPPL-146(补充) Approval Manufacturing (CMC)
1989/04/18 SUPPL-145(补充) Approval Manufacturing (CMC)
1989/04/10 SUPPL-139(补充) Approval Bioequivalence
1988/06/30 SUPPL-41(补充) Approval Labeling
1986/06/16 SUPPL-137(补充) Approval Manufacturing (CMC)
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:CHLORPROMAZINE HYDROCHLORIDE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:25MG/ML; 治疗等效代码:AP<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
080365 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP Approved Prior to Jan 1, 1982 DR REDDYS
083329 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription Yes Yes AP Approved Prior to Jan 1, 1982 HIKMA
211816 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2020/07/07 EUGIA PHARMA
217275 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2024/03/13 ZYDUS PHARMS
218229 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2024/09/24 DEVA HLDING
216911 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2024/10/04 GLAND
218272 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2024/11/18 ASPIRO
216724 001 ANDA CHLORPROMAZINE HYDROCHLORIDE CHLORPROMAZINE HYDROCHLORIDE INJECTABLE;INJECTION 25MG/ML Prescription No No AP 2024/12/10 THINQ PHARM-CRO PVT
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database